Literature DB >> 21195775

Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Prashanthi Vemuri1, Gyorgy Simon, Kejal Kantarci, Jennifer L Whitwell, Matthew L Senjem, Scott A Przybelski, Jeffrey L Gunter, Keith A Josephs, David S Knopman, Bradley F Boeve, Tanis J Ferman, Dennis W Dickson, Joseph E Parisi, Ronald C Petersen, Clifford R Jack.   

Abstract

The common neurodegenerative pathologies underlying dementia are Alzheimer's disease (AD), Lewy body disease (LBD) and frontotemporal lobar degeneration (FTLD). Our aim was to identify patterns of atrophy unique to each of these diseases using antemortem structural MRI scans of pathologically confirmed dementia cases and build an MRI-based differential diagnosis system. Our approach of creating atrophy maps using structural MRI and applying them for classification of new incoming patients is labeled Differential-STAND (Differential Diagnosis Based on Structural Abnormality in Neurodegeneration). Pathologically confirmed subjects with a single dementing pathologic diagnosis who had an MRI at the time of clinical diagnosis of dementia were identified: 48 AD, 20 LBD, 47 FTLD-TDP (pathology-confirmed FTLD with TDP-43). Gray matter density in 91 regions-of-interest was measured in each subject and adjusted for head size and age using a database of 120 cognitively normal elderly. The atrophy patterns in each dementia type when compared to pathologically confirmed controls mirrored known disease-specific anatomic patterns: AD-temporoparietal association cortices and medial temporal lobe; FTLD-TDP-frontal and temporal lobes and LBD-bilateral amygdalae, dorsal midbrain and inferior temporal lobes. Differential-STAND based classification of each case was done based on a mixture model generated using bisecting k-means clustering of the information from the MRI scans. Leave-one-out classification showed reasonable performance compared to the autopsy gold standard and clinical diagnosis: AD (sensitivity: 90.7%; specificity: 84%), LBD (sensitivity: 78.6%; specificity: 98.8%) and FTLD-TDP (sensitivity: 84.4%; specificity: 93.8%). The proposed approach establishes a direct a priori relationship between specific topographic patterns on MRI and "gold standard" of pathology which can then be used to predict underlying dementia pathology in new incoming patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21195775      PMCID: PMC3039279          DOI: 10.1016/j.neuroimage.2010.12.073

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  66 in total

1.  Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.

Authors:  Ryoko Yamamoto; Eizo Iseki; Norio Murayama; Michiko Minegishi; Wami Marui; Takashi Togo; Omi Katsuse; Masanori Kato; Takeshi Iwatsubo; Kenji Kosaka; Heii Arai
Journal:  J Neurol Sci       Date:  2006-04-19       Impact factor: 3.181

2.  Regularized linear discriminant analysis and its application in microarrays.

Authors:  Yaqian Guo; Trevor Hastie; Robert Tibshirani
Journal:  Biostatistics       Date:  2006-04-07       Impact factor: 5.899

3.  Classification of structural images via high-dimensional image warping, robust feature extraction, and SVM.

Authors:  Yong Fan; Dinggang Shen; Christos Davatzikos
Journal:  Med Image Comput Comput Assist Interv       Date:  2005

4.  Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects.

Authors:  John G Csernansky; Julia Hamstra; Lei Wang; Daniel McKeel; Joseph L Price; Mokhtar Gado; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

5.  Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias.

Authors:  O L Lopez; I Litvan; K E Catt; R Stowe; W Klunk; D I Kaufer; J T Becker; S T DeKosky
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

6.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

7.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

Authors:  K A Josephs; R C Petersen; D S Knopman; B F Boeve; J L Whitwell; J R Duffy; J E Parisi; D W Dickson
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

8.  Frontotemporal dementia: clinicopathological correlations.

Authors:  Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H Karlawish; Howard J Rosen; Vivianna Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

9.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

10.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.

Authors:  Ian R A Mackenzie; Atik Baborie; Stuart Pickering-Brown; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; David Neary; Julie S Snowden; David M A Mann
Journal:  Acta Neuropathol       Date:  2006-09-26       Impact factor: 17.088

View more
  37 in total

1.  Stereotypic behaviors in degenerative dementias.

Authors:  S Prioni; V Fetoni; F Barocco; V Redaelli; C Falcone; P Soliveri; F Tagliavini; A Scaglioni; P Caffarra; L Concari; S Gardini; F Girotti
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

2.  Suspected non-AD pathology in mild cognitive impairment.

Authors:  Laura E M Wisse; Nirali Butala; Sandhitsu R Das; Christos Davatzikos; Bradford C Dickerson; Sanjeev N Vaishnavi; Paul A Yushkevich; David A Wolk
Journal:  Neurobiol Aging       Date:  2015-09-07       Impact factor: 4.673

3.  White matter hyperintensities and imaging patterns of brain ageing in the general population.

Authors:  Mohamad Habes; Guray Erus; Jon B Toledo; Tianhao Zhang; Nick Bryan; Lenore J Launer; Yves Rosseel; Deborah Janowitz; Jimit Doshi; Sandra Van der Auwera; Bettina von Sarnowski; Katrin Hegenscheid; Norbert Hosten; Georg Homuth; Henry Völzke; Ulf Schminke; Wolfgang Hoffmann; Hans J Grabe; Christos Davatzikos
Journal:  Brain       Date:  2016-02-24       Impact factor: 13.501

4.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

5.  Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.

Authors:  Jonathan Graff-Radford; Bradley F Boeve; Otto Pedraza; Tanis J Ferman; Scott Przybelski; Timothy G Lesnick; Prashanthi Vemuri; Matthew L Senjem; Glenn E Smith; David S Knopman; Val Lowe; Clifford R Jack; Ronald C Petersen; Kejal Kantarci
Journal:  Brain       Date:  2012-07-18       Impact factor: 13.501

6.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.

Authors:  Zuzana Nedelska; Tanis J Ferman; Bradley F Boeve; Scott A Przybelski; Timothy G Lesnick; Melissa E Murray; Jeffrey L Gunter; Matthew L Senjem; Prashanti Vemuri; Glenn E Smith; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

7.  Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

Authors:  Annie M Racine; Rebecca L Koscik; Sara E Berman; Christopher R Nicholas; Lindsay R Clark; Ozioma C Okonkwo; Howard A Rowley; Sanjay Asthana; Barbara B Bendlin; Kaj Blennow; Henrik Zetterberg; Carey E Gleason; Cynthia M Carlsson; Sterling C Johnson
Journal:  Brain       Date:  2016-06-20       Impact factor: 13.501

8.  Multivariate classification of patients with Alzheimer's and dementia with Lewy bodies using high-dimensional cortical thickness measurements: an MRI surface-based morphometric study.

Authors:  Alexander V Lebedev; E Westman; M K Beyer; M G Kramberger; C Aguilar; Z Pirtosek; D Aarsland
Journal:  J Neurol       Date:  2012-12-08       Impact factor: 4.849

9.  In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.

Authors:  Veronika Hanko; Alexandra C Apple; Kathryn I Alpert; Kristen N Warren; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Lei Wang
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

10.  Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Tanis J Ferman; Bradley F Boeve; Stephen D Weigand; Scott Przybelski; Prashanthi Vemuri; Melissa E Murray; Melissa M Murray; Matthew L Senjem; Glenn E Smith; David S Knopman; Ronald C Petersen; Clifford R Jack; Joseph E Parisi; Dennis W Dickson
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.